The influence of sex, gender, age, and ethnicity on psychosocial factors and substance use throughout phases of the COVID-19 pandemic.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
31
05
2021
accepted:
24
10
2021
entrez:
22
11
2021
pubmed:
23
11
2021
medline:
15
12
2021
Statut:
epublish
Résumé
The SARS-CoV-2 (COVID-19) pandemic has had profound physical and mental health effects on populations around the world. Limited empirical research has used a gender-based lens to evaluate the mental health impacts of the pandemic, overlooking the impact of public health measures on marginalized groups, such as women, and the gender diverse community. This study used a gender-based analysis to determine the prevalence of psychosocial symptoms and substance use (alcohol and cannabis use in particular) by age, ethnicity, income, rurality, education level, Indigenous status, and sexual orientation. Participants in the study were recruited from previously established cohorts as a part of the COVID-19 Rapid Evidence Study of a Provincial Population-Based Cohort for Gender and Sex (RESPPONSE) study. Those who agreed to participate were asked to self-report symptoms of depression, anxiety, pandemic stress, loneliness, alcohol use, and cannabis use across five phases of the pandemic as well as retrospectively before the pandemic. For all psychosocial outcomes, there was a significant effect of time with all five phases of the pandemic being associated with more symptoms of depression, anxiety, stress, and loneliness relative to pre-COVID levels (p < .0001). Gender was significantly associated with all outcomes (p < .0001) with men exhibiting lower scores (i.e., fewer symptoms) than women and gender diverse participants, and women exhibiting lower scores than the gender diverse group. Other significant predictors were age (younger populations experiencing more symptoms, p < .0001), ethnicity (Chinese/Taiwanese individuals experiencing fewer symptoms, p = .005), and Indigenous status (Indigenous individuals experiencing more symptoms, p < .0001). Alcohol use and cannabis use increased relative to pre-pandemic levels, and women reported a greater increase in cannabis use than men (p < .0001). Our findings highlight the need for policy makers and leaders to prioritize women, gender-diverse individuals, and young people when tailoring public health measures for future pandemics.
Identifiants
pubmed: 34807908
doi: 10.1371/journal.pone.0259676
pii: PONE-D-21-18028
pmc: PMC8608308
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0259676Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS One. 2020 Dec 28;15(12):e0244630
pubmed: 33370404
Public Health Rep. 2014 Jan-Feb;129 Suppl 2:19-31
pubmed: 24385661
J Gen Intern Med. 2006 Jun;21(6):547-52
pubmed: 16808734
Prog Neurobiol. 2019 May;176:86-102
pubmed: 30721749
Psychiatry Res. 2020 Sep;291:113138
pubmed: 32562931
J Anxiety Disord. 2015 Apr;31:38-42
pubmed: 25725310
Psychiatry Res. 2021 Jan;295:113599
pubmed: 33285346
Front Neurosci. 2015 Jan 06;8:420
pubmed: 25610363
Am J Public Health. 2007 Jan;97(1):91-8
pubmed: 17138905
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
J Psychosom Res. 2020 Sep;136:110186
pubmed: 32682159
J Adolesc Health. 2020 Sep;67(3):354-361
pubmed: 32693983
PLoS One. 2021 Jan 25;16(1):e0245872
pubmed: 33493207
Transcult Psychiatry. 2009 Dec;46(4):623-41
pubmed: 20028680
Addict Behav. 2020 Nov;110:106532
pubmed: 32652385
J Affect Disord. 2021 Feb 15;281:91-98
pubmed: 33310451
J Affect Disord. 2020 Oct 1;275:109-111
pubmed: 32658811
Gen Hosp Psychiatry. 2011 Jan-Feb;33(1):75-7
pubmed: 21353131
Suicide Life Threat Behav. 2001 Spring;31(1):32-40
pubmed: 11326767
Br J Gen Pract. 2020 Oct 29;70(700):e817-e824
pubmed: 32988955
J Prev Med Public Health. 2020 Jul;53(4):220-227
pubmed: 32752590
Front Med (Lausanne). 2021 Mar 26;8:578959
pubmed: 33842492
BMC Psychiatry. 2020 Oct 1;20(1):480
pubmed: 33004042
Sci Rep. 2021 Apr 14;11(1):8139
pubmed: 33854103
BMJ Glob Health. 2021 Mar;6(3):
pubmed: 33753401
J Epidemiol Community Health. 2021 Mar;75(3):224-231
pubmed: 32978210
Curr HIV/AIDS Rep. 2020 Feb;17(1):35-62
pubmed: 31950336
J Affect Disord. 2020 Sep 1;274:880-896
pubmed: 32664029
Int J Environ Res Public Health. 2020 Feb 04;17(3):
pubmed: 32033010
Global Health. 2021 Apr 26;17(1):51
pubmed: 33902638
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110070
pubmed: 32800868
Int J Environ Res Public Health. 2020 Jul 02;17(13):
pubmed: 32630821
PLoS One. 2020 Jul 28;15(7):e0236562
pubmed: 32722711
Gen Psychiatr. 2020 Mar 6;33(2):e100213
pubmed: 32215365
Med Care. 2008 Mar;46(3):266-74
pubmed: 18388841
Psychol Health Med. 2021 Jan;26(1):23-34
pubmed: 32286091
J Public Health (Oxf). 2021 Apr 13;:
pubmed: 33855451
BMJ Open. 2021 May 3;11(5):e045325
pubmed: 33941630
BMC Psychiatry. 2021 Apr 28;21(1):212
pubmed: 33910550
Eur Addict Res. 2020;26(6):309-315
pubmed: 32961535
BMC Psychiatry. 2002;2:3
pubmed: 11860609
BMJ Glob Health. 2018 Mar 17;3(2):e000471
pubmed: 29607096
J Epidemiol Community Health. 2021 Nov;75(11):1078-1083
pubmed: 33980720
PLoS One. 2021 Jul 9;16(7):e0254215
pubmed: 34242317
Lancet Glob Health. 2021 Jun;9(6):e751-e752
pubmed: 33836150
Int J Environ Res Public Health. 2020 Jun 07;17(11):
pubmed: 32517294
Int J Soc Psychiatry. 2020 Aug;66(5):504-511
pubmed: 32380879
Eur Psychiatry. 2020 Sep 28;63(1):e87
pubmed: 32981568
Can J Psychiatry. 2009 May;54(5):302-11
pubmed: 19497162
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941